To investigate the effects of changes in epigenetic reaction rates on chromatin organization, we treated A375 melanoma cells with 0.5 μM trichostatin A (TSA), a well-characterized HDAC inhibitor, for 2 hours. The gene discussed is HDAC9; the disease is melanoma.